デフォルト表紙
市場調査レポート
商品コード
1485862

ナノテクノロジーによるドラッグデリバリー市場:技術タイプ別、投与形態別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年

Nanotechnology Drug Delivery Market, By Technology Type, By Mode of Administration, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 284 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ナノテクノロジーによるドラッグデリバリー市場:技術タイプ別、投与形態別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年
出版日: 2024年05月04日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ナノテクノロジーによるドラッグデリバリー市場規模は2023年に891億9,843万米ドルとなり、2024年から2032年にかけてCAGR 9.81%で拡大

ナノテクノロジーによるドラッグデリバリー市場-市場力学

慢性疾患率の上昇が先進ナノテクノロジーによるドラッグデリバリーソリューションの需要を促進

世界の慢性疾患率の上昇が、先進ナノテクノロジーによるドラッグデリバリーソリューションの需要を促進しています。例えば、世界保健機関(WHO)によると、非伝染性疾患(NCDs)は世界全体の死因の約71%を占めており、心血管疾患、がん、呼吸器疾患、糖尿病が主な原因となっています。この健康上の課題に対し、米国国立衛生研究所(NIH)のような組織は、副作用を最小限に抑えながら慢性疾患を効果的に治療できる標的ドラッグデリバリーシステムを開発するため、ナノメディシン研究への投資を増やしています。さらに、Pfizerやノバルティスなどの製薬会社は、慢性疾患の治療における治療成績と患者のコンプライアンスを高めるため、ナノテクノロジーをベースとしたドラッグデリバリープラットフォームを積極的に模索しています。このように革新的なドラッグデリバリーソリューションが重視されるようになっていることは、ナノテクノロジーの進歩を通じて慢性疾患の負担に対処することが急務であることを裏付けています。

ナノテクノロジーによるドラッグデリバリー市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024-2032年)に約9.81%のCAGRで毎年成長すると推定されます。

技術タイプセグメンテーションに基づくと、ナノ粒子が2023年に最大の市場シェアを示すと予測されました。

投与形態別では、静脈内投与が2023年の主要タイプでした。

地域別では、北米が2023年に収益を上げる主要市場です。

ナノテクノロジーによるドラッグデリバリー市場-セグメンテーション分析:

ナノテクノロジーによるドラッグデリバリーの世界市場は、技術タイプ、投与形態、用途、地域に基づいてセグメント化されます。

市場は技術タイプに基づいて5つのカテゴリーに分けられる:ナノ結晶、ナノ粒子、リポソーム、ミセル、デンドリマーです。ナノ粒子は、その汎用性と標的ドラッグデリバリーにおける有効性により、ナノテクノロジーによるドラッグデリバリー市場において支配的な技術タイプとして浮上しています。サイズと表面特性を正確に制御できるナノ粒子は、安定性、生体適合性、治療ペイロード容量を向上させ、市場普及を促進しています。

市場は投与形態に基づいて4つのカテゴリーに分けられる:経口、静脈内、経皮、吸入です。静脈内投与は、全身循環への直接アクセスと迅速な作用発現により、ナノテクノロジーによるドラッグデリバリー市場における主要な投与形態として際立っています。この形態はドラッグデリバリーを正確に制御できるため、即時の治療介入が必要な重篤な病状に適しています。

ナノテクノロジーによるドラッグデリバリー市場-地理的洞察

北米は、強固な研究インフラとヘルスケアおよびナノテクノロジーへの高い投資により市場をリードしており、Amgen Inc.やJohnson & Johnsonなどの企業が革新的なドラッグデリバリーシステムを開発しています。欧州では、スイスや英国などの国々が著しい進歩を遂げており、Roche Holding AGやAstraZeneca PLCなどの企業がナノテクノロジーに基づくソリューションに投資しています。一方、インドと日本を中心とするアジア太平洋地域は、医療費の増大と慢性疾患の蔓延によって急速な成長を遂げています。Sun Pharmaceutical Industries Ltd.や武田薬品工業のような地域のプレーヤーは、ナノテクノロジーを活用してオーダーメイドのドラッグデリバリーシステムを開発しています。

ナノテクノロジーによるドラッグデリバリー市場-競合情勢:

Amgen Inc.、Johnson & Johnson、Roche Holding AG、AstraZeneca PLCなどの大手企業が最前線に立ち、研究開発に多大な投資を行って、ナノテクノロジーに基づく新規ドラッグデリバリーシステムを革新しています。これらの企業は、治療成績と患者のコンプライアンスを改善するため、標的を絞った効率的なドラッグデリバリープラットフォームの開発に注力しています。さらに、戦略的提携、パートナーシップ、買収は、製品ポートフォリオを強化し、地理的プレゼンスを拡大するために市場プレーヤーが採用する一般的な戦略です。例えば、2022年、世界的製薬企業であるPfizerは、ナノメディシンを専門とするバイオテクノロジー企業であるBIND Therapeutics社との提携を発表しました。この提携は、ナノ粒子を利用した標的ドラッグデリバリープラットフォームであるBIND社のAccurin技術を活用し、Pfizerのがん治療薬のデリバリーを強化することを目的としています。この提携により、有効性が向上し、副作用が軽減された新規がん治療薬の開発が促進されました。新興プレーヤーや新興企業も、破壊的技術やニッチなドラッグデリバリーソリューションを導入することで、市場競争に貢献しています。

目次

第1章 ナノテクノロジーによるドラッグデリバリー市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ナノテクノロジーによるドラッグデリバリーの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ナノテクノロジーによるドラッグデリバリー産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ナノテクノロジーによるドラッグデリバリー市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ナノテクノロジーによるドラッグデリバリー市場情勢

  • ナノテクノロジーによるドラッグデリバリー市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ナノテクノロジーによるドラッグデリバリー市場:技術タイプ別

  • 概要
    • 技術タイプ別のセグメントシェア分析
    • ナノ結晶
    • ナノ粒子
    • リポソーム
    • ミセル
    • デンドリマー
    • その他

第8章 ナノテクノロジーによるドラッグデリバリー市場:投与形態別

  • 概要
    • 投与形態別のセグメントシェア分析
    • 経口
    • 静脈内
    • 経皮
    • 吸入
    • その他

第9章 ナノテクノロジーによるドラッグデリバリー市場:用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 腫瘍
    • 心血管疾患
    • 神経
    • 抗炎症/免疫
    • 抗感染
    • その他

第10章 ナノテクノロジーによるドラッグデリバリー市場:地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析:ナノテクノロジーによるドラッグデリバリー業界

  • 競争ダッシュボード
  • 企業プロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Celator Pharmaceuticals Inc
    • Celgene Corporation
    • Celsion Corporation
    • GlaxoSmithKline plc
    • Johnson &Johnson
    • Merck &Co., Inc.
    • Nanobiotix SA
    • Novartis International AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanotechnology Drug Delivery Market: Technology Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology Type
  • TABLE Global Nanotechnology Drug Delivery Market, by Technology Type 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Mode of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mode of Administration
  • TABLE Global Nanotechnology Drug Delivery Market, by Mode of Administration 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanotechnology Drug Delivery Market, by Application 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanotechnology Drug Delivery Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
目次
Product Code: ANV2766

REPORT HIGHLIGHT

Nanotechnology Drug Delivery Market size was valued at USD 89,198.43 Million in 2023, expanding at a CAGR of 9.81% from 2024 to 2032.

The Nanotechnology Drug Delivery Market, leveraging nanoscale materials for targeted and efficient drug delivery, is poised for significant growth. The potential for enhanced drug efficacy and reduced side effects, increasing investments in nanomedicine research, and the rising prevalence of chronic diseases demanding novel therapeutic solutions drive market growth. However, market growth is restrained by challenges such as regulatory complexities, concerns regarding toxicity and biocompatibility, and high research and development costs. Opportunities lie in the development of novel nanocarriers for gene therapy, personalized medicine, and the utilization of nanotechnology for overcoming biological barriers, thereby expanding the scope of drug delivery applications.

Nanotechnology Drug Delivery Market- Market Dynamics

Rising Chronic Disease Rates Propel Demand for Advanced Nanotechnology Drug Delivery Solutions

The escalating rates of chronic diseases worldwide are driving the demand for advanced nanotechnology drug delivery solutions. For instance, according to the World Health Organization (WHO), non-communicable diseases (NCDs) account for approximately 71% of all deaths globally, with cardiovascular diseases, cancer, respiratory diseases, and diabetes being the leading causes. In response to this health challenge, organizations like the National Institutes of Health (NIH) in the United States are increasingly investing in nanomedicine research to develop targeted drug delivery systems that can effectively treat chronic conditions while minimizing side effects. Additionally, pharmaceutical companies such as Pfizer and Novartis are actively exploring nanotechnology-based drug delivery platforms to enhance therapeutic outcomes and patient compliance in the treatment of chronic diseases. This growing emphasis on innovative drug delivery solutions underscores the urgent need to address the burden of chronic illnesses through nanotechnology advancements.

Nanotechnology Drug Delivery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.81% over the forecast period (2024-2032)

Based on Technology Type segmentation, Nanoparticles were predicted to show maximum market share in the year 2023

Based on Mode of Administration segmentation, Intravenous was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanotechnology Drug Delivery Market- Segmentation Analysis:

The Global Nanotechnology Drug Delivery Market is segmented on the basis of Technology Type, Mode of Administration, Application, and Region.

The market is divided into five categories based on Technology Type: Nanocrystals, Nanoparticles, Liposomes, Micelles, and Dendrimers. Nanoparticles have emerged as the dominant technology type in the Nanotechnology Drug Delivery Market due to their versatility and effectiveness in targeted drug delivery. With precise control over size and surface properties, nanoparticles offer enhanced stability, biocompatibility, and therapeutic payload capacity, driving their higher market adoption.

The market is divided into four categories based on the Mode of Administration: Oral, Intravenous, Transdermal, and Inhalation. Intravenous administration stands out as the primary mode in the Nanotechnology Drug Delivery Market, owing to its direct access to systemic circulation and rapid onset of action. This mode offers precise control over drug delivery, making it suitable for critical medical conditions requiring immediate therapeutic intervention.

Nanotechnology Drug Delivery Market- Geographical Insights

North America leads the market due to robust research infrastructure and high investments in healthcare and nanotechnology, with players like Amgen Inc. and Johnson & Johnson pioneering innovative drug delivery systems. In Europe, countries like Switzerland and the United Kingdom are witnessing significant advancements, with companies such as Roche Holding AG and AstraZeneca PLC investing in nanotechnology-based solutions. Meanwhile, the Asia Pacific region, led by India and Japan, is experiencing rapid growth fueled by increasing healthcare expenditure and rising chronic disease prevalence. Regional players like Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited are leveraging nanotechnology to develop tailored drug delivery systems.

Nanotechnology Drug Delivery Market- Competitive Landscape:

Leading companies such as Amgen Inc., Johnson & amp; Johnson, Roche Holding AG, and AstraZeneca PLC are at the forefront, investing significantly in research and development to innovate novel nanotechnology-based drug delivery systems. These companies focus on developing targeted and efficient drug delivery platforms to improve therapeutic outcomes and patient compliance. Additionally, strategic collaborations, partnerships, and acquisitions are common strategies employed by market players to strengthen their product portfolios and expand their geographic presence. For instance, in 2022, Pfizer, a global pharmaceutical company, announced a collaboration with BIND Therapeutics, a biotechnology company specializing in nanomedicine. The collaboration aimed to utilize BIND's Accurin technology, a targeted drug delivery platform utilizing nanoparticles, to enhance the delivery of Pfizer's oncology therapeutics. This partnership facilitated the development of novel cancer treatments with improved efficacy and reduced side effects. Emerging players and startups are also contributing to market competitiveness by introducing disruptive technologies and niche drug delivery solutions.

Recent Developments:

In September 2021, Nanovis announced the launch of the first and only bioceramic nanotube-enhanced pedicle screw system, nano fortifix(R), showcasing a pioneering nanotechnology-enhanced pedicle screw system with label claims to enhance bone growth

In July 2020, Curadigm Announces EUR 1 million in funding from BPI France's Deep Tech Program to Support the Development of the Nanoprimer Platform, highlighting a substantial investment in their Nanoprimer technology to enhance therapeutic bioavailability and efficacy across various drug classes

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Amgen Inc.

AstraZeneca plc

Bristol-Myers Squibb Company

Celator Pharmaceuticals Inc

Celgene Corporation

Celsion Corporation

GlaxoSmithKline plc

Johnson & Johnson

Merck & Co., Inc.

Nanobiotix S.A.

Novartis International AG

Pfizer Inc.

Roche Holding AG

Sanofi S.A.

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanocrystals
  • Nanoparticles
  • Liposomes
  • Micelles
  • Dendrimers
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Intravenous
  • Transdermal
  • Inhalation
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Neurology
  • Anti-inflammatory/Immunology
  • Anti-infective
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanotechnology Drug Delivery Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanotechnology Drug Delivery Market Snippet by Technology Type
    • 2.1.2.Nanotechnology Drug Delivery Market Snippet by Mode of Administration
    • 2.1.3.Nanotechnology Drug Delivery Market Snippet by Application
    • 2.1.4.Nanotechnology Drug Delivery Market Snippet by Country
    • 2.1.5.Nanotechnology Drug Delivery Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanotechnology Drug Delivery Key Market Trends

  • 3.1.Nanotechnology Drug Delivery Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanotechnology Drug Delivery Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanotechnology Drug Delivery Market Opportunities
  • 3.4.Nanotechnology Drug Delivery Market Future Trends

4.Nanotechnology Drug Delivery Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanotechnology Drug Delivery Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanotechnology Drug Delivery Market Landscape

  • 6.1.Nanotechnology Drug Delivery Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanotechnology Drug Delivery Market - By Technology Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Technology Type, 2023 & 2032 (%)
    • 7.1.2.Nanocrystals
    • 7.1.3.Nanoparticles
    • 7.1.4.Liposomes
    • 7.1.5.Micelles
    • 7.1.6.Dendrimers
    • 7.1.7.Others

8.Nanotechnology Drug Delivery Market - By Mode of Administration

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
    • 8.1.2.Oral
    • 8.1.3.Intravenous
    • 8.1.4.Transdermal
    • 8.1.5.Inhalation
    • 8.1.6.Others

9.Nanotechnology Drug Delivery Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Cardiovascular Diseases
    • 9.1.4.Neurology
    • 9.1.5.Anti-inflammatory/Immunology
    • 9.1.6.Anti-infective
    • 9.1.7.Others

10.Nanotechnology Drug Delivery Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Nanotechnology Drug Delivery Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Nanotechnology Drug Delivery Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Nanotechnology Drug Delivery Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Nanotechnology Drug Delivery Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Nanotechnology Drug Delivery Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Nanotechnology Drug Delivery Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.AbbVie Inc.
    • 11.2.2.Amgen Inc.
    • 11.2.3.AstraZeneca plc
    • 11.2.4.Bristol-Myers Squibb Company
    • 11.2.5.Celator Pharmaceuticals Inc
    • 11.2.6.Celgene Corporation
    • 11.2.7.Celsion Corporation
    • 11.2.8.GlaxoSmithKline plc
    • 11.2.9.Johnson & Johnson
    • 11.2.10.Merck & Co., Inc.
    • 11.2.11.Nanobiotix S.A.
    • 11.2.12.Novartis International AG
    • 11.2.13.Pfizer Inc.
    • 11.2.14.Roche Holding AG
    • 11.2.15.Sanofi S.A.
    • 11.2.16.Teva Pharmaceutical Industries Ltd.
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us